Resultados de búsqueda - Martin C. Dyroff
- Mostrando 1 - 3 Resultados de 3
-
1
-
2
-
3
Efficacy and safety results after >3.5 years of treatment with the Bruton’s tyrosine kinase inhibitor evobrutinib in relapsing multiple sclerosis: Long-term follow-up of a Phase... por Xavier Montalbán, Karolina Piasecka-Stryczyńska, Jens Kühle, Pascal Benkert, Douglas L. Arnold, Martin S. Weber, Andrea Seitzinger, Hans Guehring, Jamie Shaw, Davorka Tomic, Yann Hyvert, Danielle E. Harlow, Martin C. Dyroff, Jerry S. Wolinsky
Publicado 2024Artigo
Herramientas de búsqueda:
Materias Relacionadas
Biochemistry
Biology
Carcinogen
Chemistry
DNA
DNA damage
Gene
Molecular biology
2-Acetylaminofluorene
Adverse effect
Alternative medicine
Cancer research
Carcinogenesis
Confidence interval
DNA adduct
DNA repair
DNA synthesis
Deoxyguanosine
Environmental health
Expanded Disability Status Scale
Gastroenterology
Guanine
Hepatocellular carcinoma
Hepatocyte
Immunology
In vitro
Internal medicine
Medicine
Microsome
Multiple sclerosis